Award
Delivery Order #SPE2DR26FRRT0
Delivery Order for Xolair Medication Under Long-Term Pharmaceutical IDV
Buyer
Defense Logistics Agency
Award Amount
$9,475.32
Ceiling
$9,475.32
Awarded
February 26, 2026
Period of Performance
Feb 26, 2026 – Mar 19, 2026
Identifier
SPE2DR26FRRT0
NAICS
424210
This award represents a delivery order contract for a specific pharmaceutical product, Xolair 150 MG/ML Syringe, issued under an existing indefinite delivery vehicle (IDV) aimed at pharmaceutical procurement. The recipient, DMS Pharmaceutical Group Inc., specializes in pharmaceutical distribution, ensuring efficient and reliable delivery of essential medical supplies. The contract is significant for the agency as it supports the ongoing need for critical medications to improve public health outcomes. The scope includes the timely delivery of the specified drug within a short, defined period. This award is part of a long-term, substantial IDV contract awarded to DMS Pharmaceutical Group Inc., underscoring a strong, ongoing partnership to meet healthcare demands. The delivery order was competitively aligned with the overarching IDV, reinforcing efficient procurement practices. The performance period for this order is a concise timeframe within the broader multi-year IDV contract, facilitating swift fulfillment of immediate pharmaceutical needs.
Description
4571043157!XOLAIR 150 MG/ML SYRINGEML